Adaptive Biotechnologies Corporation (FRA:1HM)
13.84
+0.31 (2.29%)
At close: Dec 19, 2025
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 619 employees as of December 31, 2024. The number of employees decreased by 90 or -12.69% compared to the previous year.
Employees
619
Change (1Y)
-90
Growth (1Y)
-12.69%
Revenue / Employee
€348,017
Profits / Employee
€109,618
Market Cap
2.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 619 | -90 | -12.69% |
| Dec 31, 2023 | 709 | -81 | -10.25% |
| Dec 31, 2022 | 790 | -68 | -7.93% |
| Dec 31, 2021 | 858 | 236 | 37.94% |
| Dec 31, 2020 | 622 | 169 | 37.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Deutsche Post AG | 573,964 |
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
Adaptive Biotechnologies News
- 20 days ago - Chad Robins Sells 160,734 Shares of Adaptive Biotechnologies Corp - GuruFocus
- 27 days ago - Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test at Hematology Conference - GuruFocus
- 27 days ago - Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting - Wallstreet:Online
- 27 days ago - Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting - GlobeNewsWire
- 5 weeks ago - Chad Robins Sells 89,265 Shares of Adaptive Biotechnologies Corp - GuruFocus
- 5 weeks ago - Adaptive Biotechnologies (ADPT): Morgan Stanley Raises Price Target to $16 | ADPT Stock News - GuruFocus
- 6 weeks ago - Adaptive Biotechnologies Corporation 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 weeks ago - JP Morgan Raises Price Target for Adaptive Biotechnologies (ADPT) to $20 | ADPT Stock News - GuruFocus